Patient-support services programs have become common in the pharmaceutical industry and are now considered table stakes for certain disease states. Yet recent government scrutiny has left some pharma companies wondering what to do with these programs in the future.
This POV reviews the current state of affairs and lays out recommendations from overall business, compliance, legal, and regulatory viewpoints. Download it to get the details!
Related Posts
02|01|23
Exceeding Budgets & Falling Short: EVERSANA Leaders Tell Hard Truths About Omnichannel
EVERSANA leaders are raising the question the industry has been too afraid to ask aloud: Has omnichannel lived up to its promise?
01|27|23
The Issues That Matter Most in 2023: Equity
Equity is one of the five issues EVERSANA INTOUCH has identified as critical to success in 2023. Learn more!
01|19|23
The Issues That Matter Most in 2023: Medical Metaverse
The medical metaverse is one of the five issues EVERSANA INTOUCH has identified as critical to success in 2023. Learn more!